Similar to AMT-562, DB-1310 was also shown to synergize with osimertinib in EGFR-mutant NSCLC cell line xenografts and dramatically suppressed tumor growth in an osimertinib-resistant NSCLC PDX model [133]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.